Carna Biosciences, Inc. — Investor Relations & Filings
Carna Biosciences, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of small molecule kinase inhibitors. The company focuses on creating therapies for diseases with significant unmet medical needs, particularly in oncology and autoimmune disorders. Carna Biosciences operates through two core segments: a drug discovery business that advances its proprietary pipeline of drug candidates, and a drug discovery support business. The support division provides the global research community with a comprehensive portfolio of products and services, including a wide array of kinase proteins, biochemical and cell-based screening, and profiling services to accelerate pharmaceutical research and development.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 従業員に対する譲渡制限付株式としての新株式発行の払込完了に関するお知らせ | 2026-05-13 | Japanese | |
| 営業外費用及び特別損失の計上に関するお知らせ | 2026-05-08 | Japanese | |
| 2026年第1四半期決算説明資料 | 2026-05-08 | Japanese | |
| 2026年12月期第１四半期決算短信〔日本基準〕(連結) | 2026-05-08 | Japanese | |
| 従業員に対する譲渡制限付株式としての新株式発行に関するお知らせ | 2026-04-16 | Japanese | |
| 確認書 | 2026-03-26 | Japanese |
Browse filings by year
12 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 46884290 | 従業員に対する譲渡制限付株式としての新株式発行の払込完了に関するお知らせ | 2026-05-13 | Japanese | ||
| 46881913 | 営業外費用及び特別損失の計上に関するお知らせ | 2026-05-08 | Japanese | ||
| 46881911 | 2026年第1四半期決算説明資料 | 2026-05-08 | Japanese | ||
| 46881910 | 2026年12月期第１四半期決算短信〔日本基準〕(連結) | 2026-05-08 | Japanese | ||
| 46877347 | 従業員に対する譲渡制限付株式としての新株式発行に関するお知らせ | 2026-04-16 | Japanese | ||
| 33044091 | 確認書 | 2026-03-26 | Japanese | ||
| 33044089 | 有価証券報告書－第23期(2025/01/01－2025/12/31) | 2026-03-26 | Japanese | ||
| 19421838 | 訂正有価証券届出書（組込方式） | 2026-02-10 | Japanese | ||
| 13645575 | 有価証券届出書（組込方式） | 2026-01-29 | Japanese | ||
|
2025
6 filings
| |||||
| 8199625 | 訂正有価証券届出書（組込方式） | 2025-11-11 | Japanese | ||
| 7855876 | 訂正有価証券届出書（組込方式） | 2025-09-12 | Japanese | ||
| 7859020 | 訂正有価証券届出書（組込方式） | 2025-08-07 | Japanese | ||
| 7859019 | 訂正有価証券届出書（組込方式） | 2025-08-07 | Japanese | ||
| 7859017 | 確認書 | 2025-08-07 | Japanese | ||
| 7859018 | 半期報告書－第23期(2025/01/01－2025/12/31) | 2025-08-07 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
Carna Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/11390/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=11390 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=11390 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=11390 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 11390}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Carna Biosciences, Inc. (id: 11390)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.